BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5969556)

  • 1. [The inhibitory power of beta-lipoproteins on streptolysin O in blood donors from the Paris region with and without jaundice antecedents].
    Badin J; Saladin F; Barbier S
    Transfusion (Paris); 1966; 9(3):203-13. PubMed ID: 5969556
    [No Abstract]   [Full Text] [Related]  

  • 2. [The thymol and glutamic-pyruvic transaminase test in blood donors of the Paris region with or without jaundice antecedents].
    Badin J; Delaville G; Bettevy D
    Transfusion (Paris); 1966; 9(3):215-24. PubMed ID: 5969557
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of lipids of normal human beta-lipoprotein on the hemolytic action of streptolysin O and of digitonin].
    Badin J; Barillec A
    Ann Biol Clin (Paris); 1968; 26(1):213-29. PubMed ID: 5651932
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum factors in the inhibition of streptolysin O. Respective roles of antistreptolysin and beta-lipoprotein in the inhibitory titer of normal serum].
    Badin J
    Pathol Biol; 1966 Nov; 14(21):1065-70. PubMed ID: 5339824
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of the non-specific inhibition of streptolysin O. New methods of determination of the inhibiting power of beta-lipoprotein].
    Cabau N; Badin J
    Rev Fr Etud Clin Biol; 1966 May; 11(5):533-6. PubMed ID: 5938400
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fractionation of the beta-lipoproteins of the blood of subjects with hepatocellular jaundice and obstructive jaundice, using gel filtration on an agarose column].
    Padolecchia N; Maggi S; Fasano V; Trotta M; De Ceglie N; Rotunno F
    Boll Soc Ital Biol Sper; 1968 Sep; 44(18):1533-5. PubMed ID: 5732926
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of unspecific serum streptolysin O inhibitors. II. Analysis of the selective precipitation technic using heparin].
    Décourt LV; Camargo ME; Ferri RG; Kopersztych S
    Arq Bras Cardiol; 1968 Oct; 21(5):327-32. PubMed ID: 5714680
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progressive inactivation of streptolysin O incubated alone or in the presence of beta-lipoprotein. Antagonistic effect of albumin and a reducing agent].
    Badin J; Denne MA
    Ann Biol Clin (Paris); 1972; 30(5):433-8. PubMed ID: 4639764
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of the cytologic action of streptolysin O: effect of scavengers of active oxygen species and complexons on erythrocyte hemolysis].
    Nikandrov VN; Lapushkina TN
    Biull Eksp Biol Med; 1993 Mar; 115(3):277-8. PubMed ID: 8054622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of cholesterol and related sterols on haemolysis by streptolysin O.
    HOWARD JG; WALLACE KR; WRIGHT GP
    Br J Exp Pathol; 1953 Apr; 34(2):174-80. PubMed ID: 13051526
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibiting action of erythrocyte stromata on hemolysis caused by O-streptolysin. Isolation of the active fraction and study of the mechanism of action].
    Brusca AE; Cittadini AR; Donati MB; Fagiano G; Mastroeni P
    G Mal Infett Parassit; 1966 Dec; 18(12):852-6. PubMed ID: 5998987
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte stimulation with streptolysin O preparations. II. Relationship between lymphocyte-stimulating and haemolytic activities of purified streptolysin O.
    Abe Y
    Jpn J Exp Med; 1972 Apr; 42(2):131-7. PubMed ID: 4537794
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte stimulation with streptolysin O preparations. I. Purification of streptolysin O and the existence of two stimulants for rabbit lymphocytes cultured in vitro.
    Abe Y
    Jpn J Exp Med; 1971 Oct; 41(5):431-42. PubMed ID: 5316309
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dynamic of streptolysin-O hemolysis in vivo and its susceptibility to change by drugs].
    HAVA M; SYRUCEK L; RASKOVA H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1956; 73(4):415-9; discussion, 433-5. PubMed ID: 13344640
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nonspecific blood inhibitors of streptolysin O. I. Evaulation of its incidence].
    Décourt LV; Camargo ME; Kopersztych S
    Arq Bras Cardiol; 1968 Jun; 21(3):175-80. PubMed ID: 5741387
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significant decrease of rapid lipoproteins in the blood serum in patients with jaundice].
    Mincu I; Chişiu N
    Med Interna (Bucur); 1970 Jan; 22(1):49-54. PubMed ID: 5527973
    [No Abstract]   [Full Text] [Related]  

  • 17. [Titration of antistreptolysin O through streptolysin haemolytic effect inhibition (author's transl)].
    Bozdĕch V; Skácel P; Dosková M; Riedl O
    Cas Lek Cesk; 1981 Apr; 120(17):500-6. PubMed ID: 7237495
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition effect of C-reactive protein on the hemolytic activity of streptolysin O. Comparison of conformational variants].
    Nazarov PG; Berestovaia LK
    Biull Eksp Biol Med; 1995 May; 119(5):506-9. PubMed ID: 7579245
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of streptolysin O on cell membranes. I. Fixation of erythrocyte membrane].
    Alouf JE; Raynaud M
    Ann Inst Pasteur (Paris); 1968 Jun; 114(6):812-27. PubMed ID: 5760432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of electrophoretic fractioning of blood lipoproteins in jaundice and cirrhosis].
    RAYNAUD M; MINICONI P; IMBERT C; COUSTAUT A
    Rev Int Hepatol; 1957; 7(3):261-71. PubMed ID: 13442218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.